A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib

被引：0
|
作者：
Ilhan, Osman [1 ]
Seval, Guldane Cengiz [1 ]
Bozdag, Sinem Civriz [1 ]
Deveci, Burak [2 ]
Pehlivan, Mustafa [3 ]
Kaynar, Leylagul [4 ]
Yavasoglu, Irfan [5 ]
Bekoz, Huseyin [6 ]
Hindilerden, Ipek Yonal [7 ]
Yegin, Zeynep Arzu [8 ]
Dagdas, Simten [9 ]
Avsar, Ayse [10 ]
Ozkan, Atilla Hasan [11 ]
Tuglular, Tulin Firat [12 ]
Goker, Hakan [10 ]
Golbas, Zafer [13 ]
机构：
[1] Ankara Univ, Ankara, Turkey
[2] Antalya Medstar Hosp, Antalya, Turkey
[3] Gaziantep Univ, Gaziantep, Turkey
[4] Erciyes Univ, Kayseri, Turkey
[5] Adnan Menderes Univ, Aydin, Turkey
[6] Medipol Univ, Istanbul, Turkey
[7] Istanbul Univ, Istanbul, Turkey
[8] Gazi Univ, Ankara, Turkey
[9] Bilkent City Hosp, Ankara, Turkey
[10] Hacettepe Univ, Ankara, Turkey
[11] Yeditepe Univ, Istanbul, Turkey
[12] Marmara Univ, Istanbul, Turkey
[13] Anadolu Med Ctr Hosp, Kocaeli, Turkey
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P195
引用
收藏
页码：329 / 330
页数：2
相关论文
共 50 条
  • [31] Long-Term Follow-up of Ruxolitinib in Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease (GVHD)
    Ferreira, Aliana Meneses
    Molla, Vinicius Campos
    Seiwald, Maria Cristina Nunez
    Szor, Roberta Shcolnik
    De Moraes, Pedro Henrique Arruda
    Da Fonseca, Ana Rita
    Serpa, Mariana
    Xavier, Erick Menezes
    Tucunduva, Luciana
    Novis, Yana
    Arrais-Rodrigues, Celso
    BLOOD, 2020, 136
  • [32] Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
    Zeiser, R.
    Burchert, A.
    Lengerke, C.
    Verbeek, M.
    Maas-Bauer, K.
    Metzelder, S. K.
    Spoerl, S.
    Ditschkowski, M.
    Ecsedi, M.
    Sockel, K.
    Ayuk, F.
    Ajib, S.
    de Fontbrune, F. S.
    Na, I-K
    Penter, L.
    Holtick, U.
    Wolf, D.
    Schuler, E.
    Meyer, E.
    Apostolova, P.
    Bertz, H.
    Marks, R.
    Luebbert, M.
    Waesch, R.
    Scheid, C.
    Stoelzel, F.
    Ordemann, R.
    Bug, G.
    Kobbe, G.
    Negrin, R.
    Brune, M.
    Spyridonidis, A.
    Schmitt-Graeff, A.
    van der Velden, W.
    Huls, G.
    Mielke, S.
    Grigoleit, G. U.
    Kuball, J.
    Flynn, R.
    Ihorst, G.
    Du, J.
    Blazar, B. R.
    Arnold, R.
    Kroeger, N.
    Passweg, J.
    Halter, J.
    Socie, G.
    Beelen, D.
    Peschel, C.
    Neubauer, A.
    LEUKEMIA, 2015, 29 (10) : 2062 - 2068
  • [33] Denleukin diftitox (ONTAK) for the treatment of advanced steroid refractory graft-versus-host disease (SR-GVHD): A single institution experience
    Bubalo, JS
    Maziarz, RT
    Subbiah, N
    Curtin, PT
    Simic, A
    Hayes-Lattin, BM
    Schubach, SE
    Jacoby, CE
    Leis, JF
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 50 - 50
  • [34] Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
    R Zeiser
    A Burchert
    C Lengerke
    M Verbeek
    K Maas-Bauer
    S K Metzelder
    S Spoerl
    M Ditschkowski
    M Ecsedi
    K Sockel
    F Ayuk
    S Ajib
    F S de Fontbrune
    I-K Na
    L Penter
    U Holtick
    D Wolf
    E Schuler
    E Meyer
    P Apostolova
    H Bertz
    R Marks
    M Lübbert
    R Wäsch
    C Scheid
    F Stölzel
    R Ordemann
    G Bug
    G Kobbe
    R Negrin
    M Brune
    A Spyridonidis
    A Schmitt-Gräff
    W van der Velden
    G Huls
    S Mielke
    G U Grigoleit
    J Kuball
    R Flynn
    G Ihorst
    J Du
    B R Blazar
    R Arnold
    N Kröger
    J Passweg
    J Halter
    G Socié
    D Beelen
    C Peschel
    A Neubauer
    Leukemia, 2015, 29 : 2062 - 2068
  • [35] Extracorporeal photopheresis in the management of steroid-refractory chronic graft-versus-host disease after allogeneic stem cell transplantation in children: feasibility and results
    Kozlov, A.
    Guntur, S.
    Fedukova, J.
    Bykova, T.
    Moiseev, I.
    Morozova, E.
    Kulagina, I.
    Estrina, M.
    Averyanova, M.
    Zalyalov, Y.
    Kucher, M.
    Zubarovskaya, L.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S168 - S169
  • [36] Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Hattori, Kenichiro
    Doki, Noriko
    Kurosawa, Shuhei
    Hino, Yutaro
    Yamamoto, Keita
    Sakaguchi, Masahiro
    Harada, Kaito
    Ikegawa, Shuntaro
    Shingai, Naoki
    Senoo, Yasushi
    Igarashi, Aiko
    Najima, Yuho
    Kobayashi, Takeshi
    Kakihana, Kazuhiko
    Sakamaki, Hisashi
    Ohashi, Kazuteru
    ANNALS OF HEMATOLOGY, 2017, 96 (02) : 319 - 321
  • [37] Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Kenichiro Hattori
    Noriko Doki
    Shuhei Kurosawa
    Yutaro Hino
    Keita Yamamoto
    Masahiro Sakaguchi
    Kaito Harada
    Shuntaro Ikegawa
    Naoki Shingai
    Yasushi Senoo
    Aiko Igarashi
    Yuho Najima
    Takeshi Kobayashi
    Kazuhiko Kakihana
    Hisashi Sakamaki
    Kazuteru Ohashi
    Annals of Hematology, 2017, 96 : 319 - 321
  • [38] Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Ho, VT
    Zahrieh, D
    Hochberg, E
    Micale, E
    Levin, J
    Reynolds, C
    Steckel, S
    Cutler, C
    Fisher, DC
    Lee, SJ
    Alyea, EP
    Ritz, J
    Soiffer, RJ
    Antin, JH
    BLOOD, 2004, 104 (04) : 1224 - 1226
  • [39] Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Chronic Steroid-Refractory Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation
    Huang, Fen
    Du, Jing
    Lv, Pinjing
    Yang, Kaibo
    Fan, Zhiping
    Xuan, Li
    Sun, Jing
    Xu, Na
    Liu, Hui
    Shi, Pengcheng
    Li, Xiaofang
    Xu, Jun
    Wang, Zhixiang
    Wang, Pu
    Yao, Xiang
    Chen, Ye
    Liu, Qifa
    BLOOD, 2023, 142
  • [40] FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
    Przepiorka, Donna
    Luo, Lola
    Subramaniam, Sriram
    Qiu, Junshan
    Gudi, Ramadevi
    Cunningham, Lea C.
    Nie, Lei
    Leong, Ruby
    Ma, Lian
    Sheth, Christopher
    Deisseroth, Albert
    Goldberg, Kirsten B.
    Blumenthal, Gideon M.
    Pazdur, Richard
    ONCOLOGIST, 2020, 25 (02): : E328 - E334
12345